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GUIDELINES
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This is one of a series of BMJ summaries of new guidelines based on
the best available evidence; they highlight important recommendations
for clinical practice, especially where uncertainty or controversy exists.
Autism occurs in approximately 1% of children and young
people,1 though the diagnosis is made less commonly in girls2
and anyone with severe intellectual disability.1 It is one of the
most important causes of lifelong disability, with support and
lost productivity costs estimated at more than £28bn (€32bn,
$43bn) annually in the UK.3 Individual presentations vary
widely, as do associated functional impairments, but the core
features of autism are persistent impairment in reciprocal social
interaction and social communication and restricted, repetitive
patterns of behaviour, interests, or activities. These features
occur whether or not the individual has an intellectual disability
and are typically present in early childhood, though they may
be masked by parental support or compensations. Intellectual
disability, language impairment, academic deficits, and
movement disorders are common,4 and mental and behavioural
disorders are found in up to 70%.5 The presence of all these
factors, as well as sensory sensitivities, constipation, sleep and
eating problems, and behaviour that challenges, add considerably
to the impact on the child or young person, their family, and
professionals in health and social care and education.
This article summarises the most recent joint recommendations
from the National Institute for Health and Care Excellence
(NICE) and the Social Care Institute for Excellence (SCIE) on
managing autism in children and young people.6
Recommendations
NICE recommendations are based on systematic reviews of the
best available evidence and explicit consideration of cost
effectiveness. When minimal evidence is available,
recommendations are based on the Guideline Development
Group’s experience and opinion of what constitutes good
practice. Evidence levels for the recommendations are given in
italic in square brackets.
Access to health and social care services
• Ensure that all children and young people with autism have
full access to health and social care services, including
mental health services, regardless of their intellectual ability
or any coexisting diagnosis. [Based on qualitative studies
of the experience of care and the experience and expert
opinion of the Guideline Development Group (GDG)]
Organisation and delivery of services
• The assessment, management, and coordination of care for
children and young people with autism should be provided
through local, specialist, community based,
multidisciplinary teams—which should include
professionals from health, mental health, learning disability,
education, and social care services in line with NICE
clinical guidance on autism in children and young people
(CG128)7 and on autism in adults (CG142).8 [Based on
qualitative studies of the experience of care, a review of
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PRACTICE
NICE guidance on autism, and the experience and expert
opinion of the GDG]
Knowledge and competence of health and
social care professionals
Health and social care professionals working with children and
young people with autism in any setting should receive training
in autism awareness and skills in managing autism, including
• The nature and course of autism
• The nature and course of behaviour that challenges in
children and young people with autism
• Recognition of common coexisting conditions, including
- Mental health problems such as anxiety and depression
- Physical health problems such as epilepsy
- Sleep problems
- Other neurodevelopmental conditions such as
attention-deficit/hyperactivity disorder (ADHD)
• The individual’s experience of autism and its impact on
him or her
• The impact of autism on the family (including siblings) or
carers
• The impact of the social and physical environment on the
individual
• How to assess risk (including self harm, harm to others,
self neglect, breakdown of family or residential support,
exploitation or abuse by others) and develop a risk
management plan
• The changing needs that arise with puberty (including the
individual’s understanding of intimate relationships and
related problems that may occur, such as misunderstanding
the behaviour of others)
• The importance of key transition points, such as changing
schools or health or social care services
• How to provide individualised care and support and the
need for consistency of approach across home, school, and
other settings
• Skills for communicating with a child or young person.
[Based on qualitative studies of the experience of care and on
the experience and expert opinion of the GDG]
Making adjustments to the social and physical
environment and processes of care
• Take into account the physical environment in which the
individual is supported and cared for and minimise any
negative impact by making reasonable adjustments or
adaptations to the setting, including
- Visual supports (such as words, pictures, or symbols at
a level that is meaningful for the person)
- Sensory challenges such as colour of walls and
furnishings, lighting, or noise levels
- Amount of personal space given.
[Based on qualitative studies of the experience of care and
the experience and opinion of the GDG]
Interventions for the core features of autism
• For the core features of autism, consider a specific social
communication intervention that includes play based
strategies with parents, carers, and teachers to increase
joint attention, engagement, and reciprocal communication
in the child or young person. Strategies should
- Be adjusted to the individual’s developmental level
- Aim to increase the parents’, carers’, teachers’, or peers’
understanding of and sensitivity and responsiveness to the
individual’s patterns of communication and interaction
- Include techniques of therapist modelling and video
interaction feedback
- Include techniques to expand the individual’s
communication, interactive play, and social routines.
The intervention should be delivered by a trained professional.
For preschool children, consider parent, carer, or teacher
mediation. For school aged children, consider peer mediation.
[Based on low to moderate quality randomised controlled trials
for caregiver and teacher mediated interventions and very low
quality randomised controlled trials for peer mediated
interventions]
• Do not use antipsychotics, antidepressants, anticonvulsants,
and exclusion diets (such as gluten-free or casein-free diets)
to manage the core features of autism because the balance
of risks (especially with anticonvulsants and exclusion
diets) and benefits did not favour their use. [Based on
moderate to very low quality randomised controlled trials
for antipsychotics, antidepressants, and anticonvulsants;
low to very low quality randomised controlled trials for
exclusion diets; and the experience and expert opinion of
the GDG]
Interventions for autism that should not be
used in any context
• Do not use secretin, chelation, or hyperbaric oxygen
therapy to manage autism in any context because there is
no clear evidence that these are effective and because there
is harm associated with their use. [Based on moderate to
very low quality randomised controlled trials for secretin,
low to very low quality randomised controlled trials for
chelation and hyperbaric oxygen therapy, and the
experience and expert opinion of the GDG]
Interventions for behaviour that challenges
• In routine assessment and care planning, assess factors that
may increase the risk of behaviour that challenges,
including
- Impairments in communication that may result in
difficulty understanding situations or expressing needs and
wishes
- Coexisting physical disorders (such as pain or
gastrointestinal disorders), mental health problems (such
as anxiety or depression), and other neurodevelopmental
conditions (such as ADHD)
- The physical environment, such as lighting and noise
levels
- The social environment, including home, school, and
leisure activities
- Changes to routines or personal circumstances
- Developmental change, including puberty
- Exploitation or abuse by others
- Inadvertent reinforcement of behaviour that challenges
- The absence of predictability and structure.
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[Based on the experience and expert opinion of the GDG]
• If no coexisting mental health or behavioural problem,
physical disorder, or environmental problem has been
identified as triggering or maintaining the behaviour that
challenges, offer a psychosocial intervention (informed by
a functional assessment of behaviour) as a first line
treatment. [Based on the experience and expert opinion of
the GDG]
• Consider antipsychotic medication for managing behaviour
that challenges when psychosocial or other interventions
are insufficient or could not be delivered because of the
severity of the behaviour. Antipsychotic medication should
be initially prescribed and monitored by a paediatrician or
psychiatrist, who should
- Identify the target behaviour
- Decide on an appropriate measure to monitor
effectiveness, including frequency and severity of the
behaviour and a measure of global impact
- Review the effectiveness and any side effects of the
medication after three to four weeks
- Stop treatment if there is no indication of a clinically
important response at six weeks.
[Based on low to moderate quality randomised controlled
trials for efficacy of antipsychotic medication and the
experience and expert opinion of the GDG for prescribing
and monitoring considerations]
Interventions for sleep problems
• If the individual has a sleep problem offer an assessment
that identifies
- What the sleep problem is (for example, delay in falling
asleep, frequent waking, unusual behaviours, breathing
problems, or sleepiness during the day)
- Day and night sleep patterns, and any change to those
patterns
- Whether bedtime is regular and what the sleep
environment is like
- Presence of comorbidities, especially those that feature
hyperactivity or other behavioural problems
- Levels of activity and exercise during the day
- Possible physical illness or discomfort
- Effects of any medication
- Individual factors such as emotional relationships or
problems at school
- The impact on parents, other family members, or carers.
[Based on the experience and expert opinion of the GDG]
Families and carers
• Offer families (including siblings) and carers an assessment
of their own needs, including whether they have
- Personal, social, and emotional support
- Practical support in their caring role, including short
breaks and emergency plans
- A plan for future care for the child or young person,
including transition to adult services.
[Based on qualitative studies of the experience of care and
the experience and opinion of the GDG]
Transition to adult services
• For young people aged 16 or older whose needs are
complex or severe, use the care programme approach9 in
England (care and treatment plans in Wales) to coordinate
their needs and as an aid to transfer between services.
- Involve the young people in the planning and, where
appropriate, their parents or carers
- Provide information about adult services to the young
people, and their parents or carers, including their right to
a social care assessment at age 18.
[Based on the experience and opinion of the GDG]
Overcoming barriers
Currently, widespread inconsistency in access to and provision
of care and effective interventions (for autism and for physical
andmental health problems) are potential challenges to guideline
implementation. However, establishing local autism strategy
groups andmultidisciplinary autism teams should help to resolve
this problem and improve access to care. Moreover, in
differentiating interventions for the core features of autism,
associated problems, and coexisting physical and mental health
problems, the guideline will help people access effective
treatments and prevent them from being offered ones that are
ineffective or harmful. Provision of social care is also variable
and sometimes inadequate; to help overcome this challenge, the
guideline advises integrating health and social care within the
multidisciplinary autism team and recommending social support
for the child and his or her parents.
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Further information on the guidance
There is wide variation in access to and quality of intervention services despite recent clinical guidance in the UK.10-12 Many families report
that they experience difficulties in getting a diagnosis of autism confirmed, delays in accessing specific interventions, a lack of understanding
about the way autism affects an individual, and problems accessing help for physical and mental health problems and behaviour that
challenges.13 Professionals may not recognise that additional mental and behavioural problems are distinct disorders and therefore may not
offer effective treatments (for example, cognitive behavioural therapy for anxiety and psychostimulants for ADHD symptoms). Young people
with intellectual difficulties and their parents may have particular challenges accessing skilled help through generic services.
The level and form of social care provided are also highly variable and often determined by historical patterns of service development rather
than by needs or evidence. Surveys indicate that families feel inadequately provided with services such as occupational therapy, respite
care and short breaks, information and advocacy, and preparing for the transition to adult services.14 Social care services for children and
young people are often generic, without sufficient understanding of the distinct complexities of autism: eligibility criteria for services may
lack relevance, and intervention may be available only when a crisis has been reached.15
Methods
This guideline was developed by the National Collaborating Centre for Mental Health using NICE’s guideline methods (http://publications.
nice.org.uk/the-guidelines-manual-pmg6). The guideline review process involved comprehensive and systematic literature searches to
identify relevant evidence for the clinical and economic reviews, with critical appraisal of the quality of the identified evidence. A multidisciplinary
team of health and social care professionals from psychiatry, psychology, paediatrics, speech and language therapy, occupational therapy,
general practice, nursing, social work, and education, as well as representatives of service users and carers (the GDG), was established to
review the evidence and develop the subsequent recommendations. The guideline then went through an external consultation with stakeholders.
The GDG considered the stakeholders’ comments, reanalysed the data where necessary, and modified the guideline as appropriate.
NICE has produced three different versions of the guideline: a full version; a summary version known as the “NICE guideline”; and a version
for children and young people with autism, their parents and carers, and the public. All these versions, as well as a pathway, are available
from the NICE website (http://guidance.nice.org.uk/CG170). Updates of the guideline will be produced as part of NICE’s guideline development
programme.
Areas for future research
• The value of a key worker approach (which is defined by protocol and delivered in addition to usual care)—for children and young
people with autism in terms of parental satisfaction, functioning and stress, and child psychopathology.
• The clinical and cost effectiveness of
- Group based parent training intervention (compared with treatment as usual) for parents or carers of children and young people with
autism in reducing early and emerging behaviour that challenges in the short and medium term
- Sleep hygiene intervention or melatonin to treat problems with sleep onset, night waking, and reduced total sleep in children aged
4-10 years with autism
- Pharmacological and psychosocial interventions for anxiety disorders in children and young people with autism.
• The effectiveness of comprehensive early interventions that combine multiple elements and delivery by parents and teachers in
managing core autism symptoms and coexisting difficulties in children of preschool age.
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